1 completed, 1 not yet recruiting, 1 terminated. 2 Phase 4, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Completed 1, Not yet recruiting 1 |
| Phase 1 | 1 | Terminated 1 |
Follow PegIFN alfa-2b: new trials by email Literature Review of PegIFN alfa-2b trials Research Report on PegIFN alfa-2b
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pegylated Interferon Alfa-2b in Reducing Relapse Rates After Nucleos(t)ide Analogue Withdrawal in HBeAg-negative CHB Patients with Low Level HBsAg PegIFN alfa-2b, PegIFN alfa-2b and NUC - Chronic Hepatitis B | Phase 4 | Not yet recruiting | Huashan Hospital | 360 | 2025-04-01 | 2025-03-28 |
| A Study of Pegylated Interferon Alfa-2b (MK-4031) as an Adjuvant Treatment in Japanese Patients With Malignant Melanoma (MK-4031-370) PegIFN alfa-2b - Malignant Melanoma | Phase 1 | Terminated | Merck Sharp & Dohme LLC | 9 | 2012-12-25 | 2018-08-08 |
| Lowering Viral Load With Nucleos(T)Ide Analogues Prior to Peginterferon Treatment to Ncrease Sustained Response in CHB PegIFN alfa-2b - Chronic Hepatitis B | Phase 4 | Completed | Foundation for Liver Research | 82 | 2012-06-01 | 2019-01-04 |
Hepatitis B, Chronic (2) · Hepatitis B (1) · Melanoma (1)
Foundation for Liver Research (1) · Huashan Hospital (1) · Merck Sharp & Dohme LLC (1)
China (2) · Netherlands (1)